Sign in

Proton pump inhibitors & Gastroesophageal Reflux Disease

Last updated: 19 Nov 2026 incl. AI

Sources: PubMed

Do proton pump inhibitors cause gastroesophageal reflux disease?

Checked

Posts say that heartburn pills that cut stomach acid cause reflux disease or make it more likely.

We found no study showing that proton pump inhibitors cause gastroesophageal reflux disease.

What studies show

As of , we found no study on proton pump inhibitors and gastroesophageal reflux disease. We found 1,496 published papers on proton pump inhibitors and gastroesophageal reflux disease. They were published between 2016 and 2027. 548 of them are studies in people. 388 of them followed or compared people without deciding who got it (observational studies). Such studies can show a link, but not that one thing causes the other. At least 944 people took part. 119 of them were fair tests in which chance decided who got it and who did not. 18 were studies in animals, and 1 was only in cells in the lab. 444 papers are reviews that sum up other studies. 1 paper was retracted.

Trials in people

A 2026 Japanese trial of 63 people tested stopping these pills at once or slowly. About 3 in 4 people in each group stopped successfully at 24 weeks. A 2026 trial of 692 people compared a capsule with double-dose omeprazole for heartburn-free days. It tested symptom control, not whether the pills cause reflux. Two more 2026 trials looked at ways to help people stop these pills.

Other studies in people

A 2026 study of 14 people found a link between these pills and reflux. It is too small to say whether one caused the other. A 2026 study of 1,308 lung transplant patients did not look at when reflux began. Studies that only watch people show a link and cannot show cause and effect.

Reviews

A 2026 review lists possible risks of long-term use, such as kidney disease and dementia. Reflux is not on that list. A 2026 review of 1,495 people found these pills eased night-time heartburn compared with placebo.

In animals

A 2023 study in pregnant mice looked at tooth changes in their pups, not reflux. A 2022 study in rats studied how reflux arises, not whether these pills cause it. Results in animals do not always hold in people.

In the lab

A 2019 lab study looked at stomach fluid damaging airway cells, not at reflux starting.

Other papers

A 2026 report of one woman described stomach tumours after 20 years on these pills. It says nothing about the pills causing reflux.

What this means for you

Our verdict: Unproven.

No study in people has tested whether these pills cause reflux. Studies that only watch people show links at most, and animal and lab studies did not look at reflux starting. So the claim is unproven.

Do not decide anything about proton pump inhibitors because of one story or post. No study we found shows whether it raises the risk. If you are worried about your risk of gastroesophageal reflux disease, talk to your doctor.

This page explains what research has found so far. It is not medical advice. Talk to your doctor before you start, stop or change any treatment.

We searched 18 scientific databases for research from the last 10 years (since 18 Nov 2016).

Sources

  1. Immediate discontinuation versus gradual tapering of proton pump inhibitors in long-term users: a randomized controlled trial. J Gastroenterol 2026. Randomised trial. PubMed
  2. Sucralfate/Sodium Alginate Capsules and Proton Pump Inhibitor-Refractory Reflux Symptoms in Nonerosive Reflux Disease and Mild Erosive Disease: A Randomized, Phase 3, Noninferiority Study. Dig Dis 2026. Randomised trial. PubMed
  3. An App-Based Proton Pump Inhibitor Discontinuation Tool: A Multicentre, Open-Label, Randomised Superiority Trial. United European Gastroenterol J 2026. Randomised trial. PubMed
  4. Deprescribing Intervention and Reduction of Proton Pump Inhibitor Use in Primary Care: A Cluster Randomized Clinical Trial. JAMA Intern Med 2026. Randomised trial. PubMed
  5. Long-Term Proton Pump Inhibitors in Lung Transplant Recipients: Near-Universal Use Without Clear Impact on Clinical Outcomes Over a 20-Year Observational Study. Clin Transplant 2026. Observational study in people. PubMed
  6. Small neuroendocrine proliferations in columnar mucosa at or near the gastroesophageal junction: a finding potentially related to proton pump inhibitor use and/or gastroesophageal reflux disease. Histopathology 2026. Observational study in people. PubMed
  7. PPI-refractory GERD in SSc is driven by distinct oesophageal and gastric motility abnormalities. Rheumatology (Oxford) 2026. Observational study in people. PubMed
  8. Guiding Proton Pump Inhibitor Use Across Common Clinical Settings: A Narrative Review of Guidelines and Expert Consensus. J Gen Intern Med 2026. Review. PubMed
  9. Efficacy of Proton Pump Inhibitor Therapy for Nocturnal GERD Symptoms and Associated Sleep Disturbances: A Systematic Review of Randomized Controlled Trials. J Clin Gastroenterol 2026. Review. PubMed
  10. Gastrointestinal microbiota alterations associated with pediatric gastroesophageal reflux disease and proton pump inhibitor exposure: a systematic review of microbiome changes, dysbiosis markers, and associated clinical outcomes. Front Nutr 2026. Review. PubMed
  11. Gastric neuroendocrine tumours after prolonged proton pump inhibitor use. BMJ Case Rep 2026. Other paper. PubMed
  12. Proton Pump Inhibitor-Associated Hypomagnesemia: A Case Report Highlighting a Rare Adverse Effect. Cureus 2026. Other paper. PubMed
  13. Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease. Biomed Rep 2025. Study in people. PubMed
  14. Intrauterine exposure to omeprazole increases the risk of teeth morphological anomalies in the offspring of a murine model. Odontology 2023. In animals. PubMed
  15. EZH2-mediated suppression of CLDN1 leads to barrier dysfunction in PPI-refractory gastroesophageal reflux disease. Dig Liver Dis 2022. In animals. PubMed
  16. Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium. Sci Rep 2019. In the lab. PubMed

Frontlight Community

Share what you saw, tried or were told about this claim, and read what others went through. Posts are not medical advice: ask your doctor about your own treatment.

Be the first to share your experience or your question about this claim

Research you can look at next

Open trials and published studies linked to this claim, each with its source and date.

This page explains what research has found so far. It is not medical advice. Talk to your doctor before you start, stop or change any treatment.

More checked claims